163 related articles for article (PubMed ID: 27287269)
1. Expression of C-KIT, CD24, CD44s, and COX2 in benign and non-invasive apocrine lesions of the breast.
Tramm T; Kim JY; Leibl S; Moinfar F; Tavassoli FA
Virchows Arch; 2016 Sep; 469(3):285-95. PubMed ID: 27287269
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical analysis of apocrine breast lesions. Consistent over-expression of androgen receptor accompanied by the loss of estrogen and progesterone receptors in apocrine metaplasia and apocrine carcinoma in situ.
Gatalica Z
Pathol Res Pract; 1997; 193(11-12):753-8. PubMed ID: 9521507
[TBL] [Abstract][Full Text] [Related]
3. Cell turnover in apocrine metaplasia and apocrine adenosis of the breast.
Elayat G; Selim AG; Wells CA
Ann Diagn Pathol; 2010 Feb; 14(1):1-7. PubMed ID: 20123450
[TBL] [Abstract][Full Text] [Related]
4. Characterization of breast precancerous lesions and myoepithelial hyperplasia in sclerosing adenosis with apocrine metaplasia.
Celis JE; Moreira JM; Gromova I; Cabezón T; Gromov P; Shen T; Timmermans V; Rank F
Mol Oncol; 2007 Jun; 1(1):97-119. PubMed ID: 19383289
[TBL] [Abstract][Full Text] [Related]
5. The clinicopathological and prognostic significance of CD24, CD44, CD133, ALDH1 expressions in invasive ductal carcinoma of the breast: CD44/CD24 expression in breast cancer.
Kapucuoğlu N; Bozkurt KK; Başpınar Ş; Koçer M; Eroğlu HE; Akdeniz R; Akçil M
Pathol Res Pract; 2015 Oct; 211(10):740-7. PubMed ID: 26298632
[TBL] [Abstract][Full Text] [Related]
6. Cancer stem cells markers CD44, CD24 and ALDH1 in breast cancer special histological types.
de Beça FF; Caetano P; Gerhard R; Alvarenga CA; Gomes M; Paredes J; Schmitt F
J Clin Pathol; 2013 Mar; 66(3):187-91. PubMed ID: 23112116
[TBL] [Abstract][Full Text] [Related]
7. CD10 Immunohistochemical Expression in Apocrine Lesions of the Breast.
Kővári B; Báthori Á; Cserni G
Pathobiology; 2015; 82(6):259-63. PubMed ID: 26562027
[TBL] [Abstract][Full Text] [Related]
8. Molecular characterization of CD44
Da Cruz Paula A; Leitão C; Marques O; Rosa AM; Santos AH; Rêma A; de Fátima Faria M; Rocha A; Costa JL; Lima M; Lopes C
Virchows Arch; 2017 Mar; 470(3):311-322. PubMed ID: 28116522
[TBL] [Abstract][Full Text] [Related]
9. CD44s is useful in the differentiation of benign and malignant papillary lesions of the breast.
Tse GM; Tan PH; Ma TK; Gilks CB; Poon CS; Law BK
J Clin Pathol; 2005 Nov; 58(11):1185-8. PubMed ID: 16254109
[TBL] [Abstract][Full Text] [Related]
10. Diminished number or complete loss of myoepithelial cells associated with metaplastic and neoplastic apocrine lesions of the breast.
Tramm T; Kim JY; Tavassoli FA
Am J Surg Pathol; 2011 Feb; 35(2):202-11. PubMed ID: 21263240
[TBL] [Abstract][Full Text] [Related]
11. The clinicopathological significance of CD44+/CD24-/low and CD24+ tumor cells in invasive micropapillary carcinoma of the breast.
Li W; Liu F; Lei T; Xu X; Liu B; Cui L; Wei J; Guo X; Lang R; Fan Y; Gu F; Tang P; Zhang X; Fu L
Pathol Res Pract; 2010 Dec; 206(12):828-34. PubMed ID: 20977976
[TBL] [Abstract][Full Text] [Related]
12. Predictive value of CD44 and CD24 for prognosis and chemotherapy response in invasive breast ductal carcinoma.
Chen Y; Song J; Jiang Y; Yu C; Ma Z
Int J Clin Exp Pathol; 2015; 8(9):11287-95. PubMed ID: 26617852
[TBL] [Abstract][Full Text] [Related]
13. The diagnostic utility of EZH2 H-score and Ki-67 index in non-invasive breast apocrine lesions.
Vougiouklakis T; Belovarac BJ; Lytle A; Chiriboga L; Ozerdem U
Pathol Res Pract; 2020 Sep; 216(9):153041. PubMed ID: 32825929
[TBL] [Abstract][Full Text] [Related]
14. Apocrine epithelium of the breast: does it result from metaplasia?
Viacava P; Naccarato AG; Bevilacqua G
Virchows Arch; 1997 Sep; 431(3):205-9. PubMed ID: 9334842
[TBL] [Abstract][Full Text] [Related]
15. [Quantity and distribution of CD44+/CD24- cells in breast cancer tissue and the cell lines].
Lü XQ; Suo Z; Ma CL; Xu KJ; Liu YS; Li HX
Zhonghua Bing Li Xue Za Zhi; 2009 Jul; 38(7):441-4. PubMed ID: 19781189
[TBL] [Abstract][Full Text] [Related]
16. Molecular characterization of apocrine carcinoma of the breast: validation of an apocrine protein signature in a well-defined cohort.
Celis JE; Cabezón T; Moreira JM; Gromov P; Gromova I; Timmermans-Wielenga V; Iwase T; Akiyama F; Honma N; Rank F
Mol Oncol; 2009 Jun; 3(3):220-37. PubMed ID: 19393583
[TBL] [Abstract][Full Text] [Related]
17. CD44(+)/CD24(-/low) cancer stem/progenitor cells are more abundant in triple-negative invasive breast carcinoma phenotype and are associated with poor outcome.
Idowu MO; Kmieciak M; Dumur C; Burton RS; Grimes MM; Powers CN; Manjili MH
Hum Pathol; 2012 Mar; 43(3):364-73. PubMed ID: 21835433
[TBL] [Abstract][Full Text] [Related]
18. Distribution of CD44/CD24 positive cells in ductal invasive carcinoma of breast of different grade and molecular subtype.
Gudadze M; Kankava K; Mariamidze A; Mosidze T; Burkadze G
Georgian Med News; 2013 Sep; (222):50-7. PubMed ID: 24099815
[TBL] [Abstract][Full Text] [Related]
19. Features of CD44+/CD24-low phenotypic cell distribution in relation to predictive markers and molecular subtypes of invasive ductal carcinoma of the breast.
Gudadze M; Kankava Q; Mariamidze A; Burkadze G
Georgian Med News; 2014 Mar; (228):81-7. PubMed ID: 24743129
[TBL] [Abstract][Full Text] [Related]
20. Clinical implications of CD44+/CD24- tumor cell ratio in breast cancer.
Liu C; Luo Y; Liu X; Lu P; Zhao Z
Cancer Biother Radiopharm; 2012 Jun; 27(5):324-8. PubMed ID: 22702496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]